Previous Article | Next Article ![]()
Journal of Virology, December 1998, p. 10073-10082, Vol. 72, No. 12
Departments of Internal Medicine and
Biological Chemistry, Howard Hughes Medical Institute, University
of Michigan Medical Center, Ann Arbor, Michigan
48109-0650,1 and
Skin Disease
Research Laboratories, Department of Pathology, Cardinal Bernardin
Cancer Center, Loyola University Medical Center, Maywood, Illinois
60153-53852
Received 9 March 1998/Accepted 9 September 1998
The DNA sequence for Kaposi's sarcoma-associated herpesvirus was
originally detected in Kaposi's sarcoma biopsy specimens. Since its
discovery, it has been possible to detect virus in cell lines
established from AIDS-associated body cavity-based B-cell lymphoma
and to propagate virus from primary Kaposi's sarcoma lesions in a
human renal embryonic cell line, 293. In this study, we analyzed the
infectivity of Kaposi's sarcoma-associated herpesvirus produced from these two sources. Viral isolates from cultured cutaneous
primary KS cells was transmitted to an Epstein-Barr virus-negative
Burkitt's B-lymphoma cell line, Louckes, and compared to virus induced
from a body cavity-based B-cell lymphoma cell line. While propagation
of body cavity-based B-cell lymphoma-derived virus was not observed in
293 cell cultures, infection with viral isolates obtained from primary
Kaposi's sarcoma lesions induced injury in 293 cells typical of
herpesvirus infection and was associated with apoptotic cell death.
Interestingly, transient overexpression of the Kaposi's
sarcoma-associated herpesvirus v-Bcl-2 homolog delayed the process of
apoptosis and prolonged the survival of infected 293 cells. In
contrast, the broad-spectrum caspase inhibitors Z-VAD-fmk and
Z-DEVD-fmk failed to protect infected cell cultures, suggesting that
Kaposi's sarcoma-associated herpesvirus-induced apoptosis occurs
through a Bcl-2-dependent pathway. Kaposi's sarcoma-associated herpesvirus isolates from primary Kaposi's sarcoma lesions and body
cavity-based lymphomas therefore may differ and are likely to have
distinct contributions to the pathophysiology of Kaposi's sarcoma.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Distinct Biology of Kaposi's Sarcoma-Associated
Herpesvirus from Primary Lesions and Body Cavity Lymphomas
*
Corresponding author. Mailing address: Howard Hughes
Medical Institute, University of Michigan Medical Center, Departments of Internal Medicine and Biological Chemistry, 1150 W. Medical Center
Dr., 4520 MSRB I, Ann Arbor, MI 48109-0650. Phone: (734) 647-4798. Fax:
(734) 647-4730. E-mail: gnabel{at}umich.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»